(Press-News.org) An article published in NPJ Aging, a Springer Nature journal, reveals that natural production of auto-antibodies increases with age and that infection by SARS-CoV-2 can exacerbate production of auto-antibodies relating to auto-immune diseases, helping to explain why aging increases the chances of developing severe COVID-19. The study also discovered some of the factors that associate the severe form of the disease with blood clotting disorders such as thrombosis.
“These findings open the door to a better understanding of many pathological events associated with COVID-19, ranging from memory loss to sudden death from acute thrombosis. The hyperinflammation typical of severe COVID-19 and the increase in auto-antibodies produce blood clotting, resulting in the need to reconstruct tissue and recruit a coagulation cascade. Thrombosis and inflammation are closely correlated. Our study is one more confirmation of this important link,” Otávio Cabral-Marques, a professor at the University of São Paulo’s Medical School (FM-USP) in Brazil and last author of the article, told Agência FAPESP.
The study was supported by FAPESP (projects 18/18886-9, 20/01688-0, 20/07069-0, 20/16246-2 and 20/09146-1). Researchers in Germany and the United States collaborated.
Another interesting aspect of the study, according to Cabral-Marques, is that the rise in levels of auto-antibodies – antibodies (immune proteins) that may harmfully react with a person’s own tissues or organs – in severe COVID-19 cases could also be true of other pathologies.
“It’s not exclusive to SARS-CoV-2. Other pathogens also raise levels of auto-antibodies, so that they can serve as markers or therapeutic targets to save the lives of patients with almost terminal sepsis, for example,” Cabral-Marques said.
The study involved an analysis of auto-antibody data for 159 COVID-19 patients (71 mild, 61 moderate, and 27 severe) and 72 healthy individuals as the control group. “When we cross-referenced the data using artificial intelligence techniques, we discovered two main auto-antibodies that were exacerbated in patients with severe symptoms. They were precisely the auto-antibodies associated with blood clotting and thrombocytopenia [low blood platelet count, heightening the risk of hemorrhage],” said Dennyson Leandro M. Fonseca, first author of the article.
High levels of these auto-antibodies, he explained, can lead the organism to harm itself by producing blood clots and netosis – an immune system mechanism involving regulated cell death via the formation of neutrophil extracellular traps (NETs), networks of DNA that bind to pathogenic microbes. In certain cases, NETs serve as markers of alveolar inflammation and may contribute to tissue injury.
“When we divided the data into younger and older patients, we found that although this mechanism may occur in under-50s, it makes the elderly more susceptible to severe COVID-19. This explains why old age is one of the main risk factors for COVID-19,” he said.
As noted, a mild increase in production of auto-antibodies is part of the natural aging process, but the researchers observed that infection by SARS-CoV-2 exacerbates levels of auto-antibodies in severe patients.
Previous studies showed that auto-antibodies targeting proteins in the first line of anti-viral defense (interferons) are present in the general population and increase dramatically in older COVID-19 patients. The study reported in NPJ Aging extends the classes of auto-antibodies associated with aging and confirms that their impact varies according to age and COVID-19 severity.
The group discovered that severe COVID-19 patients display a significant age-related increase in auto-antibodies against 16 targets, including amyloid β peptide, β catenin, cardiolipin, claudin, enteric nerve, fibulin, insulin receptor A and platelet glycoprotein.
“This discovery provides new avenues for validation of the action mechanism of auto-antibodies and broadens the pool of targets, providing a more comprehensive picture of the underlying pathophysiology of COVID-19 disease progression with the advance of aging and permitting more suitable interventions,” Cabral-Marques said.
Systemic problem
Severe COVID-19 is known to cause profound organ damage due to a combination of auto-inflammatory and auto-immune responses. This process can result in myopathy (muscle disorders), vasculitis (blood vessel inflammation), arthritis (joint inflammation), anti-phospholipid syndrome (APS) associated with deep vein thrombosis, pulmonary embolism and stroke, as well as other damage to lungs, kidneys and the neurological system.
Immunological dysregulation is also frequent in post-COVID syndrome, causing heterogeneous symptoms such as fatigue, vascular dysfunction, pain, neurological manifestations and neuropsychiatric problems.
The most well-known inflammatory response associated with COVID-19 is the “cytokine storm”, which basically consists of heightened release of cytokines (the molecules responsible for alerting the immune system to the need to send more defense cells to the infection site), leading to exacerbated inflammation and dysregulation of other signaling systems. Another is hyperactivation of macrophages, immune system cells that promote auto-antibody production.
Which comes first?
The authors of the article are not yet sure which comes first – the severity of COVID-19 or the rise in levels of auto-antibodies. “We analyzed these two directions statistically and believe they’re both mutual and bidirectional,” Fonseca said. “Auto-antibodies may interact, in conjunction with other immune system molecules, in a highly complex network that underlies immunopathological processes in severe COVID-19, or they may be boosted by health problems associated with aging and make the disease progress to a severe condition.”
Severe COVID-19, he noted, promotes an environment in the organism involving tissue injury (acute respiratory distress syndrome), cytokine storm and macrophage hyperactivation, all of which fosters the production of auto-antibodies. In turn, this context could allow auto-antibodies to act synergistically with multiple metabolites, cytokines and chemokines, which are naturally dysregulated in elderly patients as part of immunosenescence, resulting in increased susceptibility to infections and auto-immune disorders.
About São Paulo Research Foundation (FAPESP)
The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. You can learn more about FAPESP at www.fapesp.br/en and visit FAPESP news agency at www.agencia.fapesp.br/en to keep updated with the latest scientific breakthroughs FAPESP helps achieve through its many programs, awards and research centers. You may also subscribe to FAPESP news agency at http://agencia.fapesp.br/subscribe.
END
COVID-19 can trigger auto-immune disorders-related antibodies, causing thrombosis and other complications
A study conducted at the University of São Paulo helps explain why older people are more susceptible to the severe form of the disease and why it involves blood clotting disorders
2023-09-12
ELSE PRESS RELEASES FROM THIS DATE:
Alzheimer’s: An M.D./Ph.D. graduate student’s request for Yuhua Song as mentor leads to two NIH R01 awards totaling $5 million
2023-09-12
BIRMINGHAM, Ala. – In the summer of 2018, graduate student Hunter Dean from the Medical Scientist Training Program came to Yuhua Song, Ph.D., with a research idea. He wanted to pursue his doctoral research at the University of Alabama at Birmingham in Alzheimer’s disease — under the joint mentorship of Song, who had never worked in Alzheimer’s, and Erik Roberson, M.D., Ph.D., an Alzheimer’s expert in the UAB Department of Neurology and the Center for Neurodegeneration and Experimental Therapeutics, or CNET.
That collaboration brought Song, a professor in the UAB Department of ...
Recommendations for addressing health-related social needs in cancer care introduced at NCCN Policy Summit
2023-09-12
Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—presented new recommendations for screening and addressing health-related social needs (HRSN) in people with cancer during a policy summit in Washington, D.C. The event included a keynote address from Ellen Lukens, Deputy Administrator and Director, The Center for Medicare and Medicaid Innovation (CMMI), and other speakers representing a diverse group of patient advocates, providers, and policymakers.
The new recommendations for measuring and addressing HRSNs were ...
West Health-Gallup Poll: 70% of Americans uncomfortable with prospect of being admitted to nursing home
2023-09-12
WASHINGTON, D.C. — September 12, 2023 — More than 40% of Americans say nursing homes are unsafe and 7 in 10 say they would be uncomfortable ever having to be admitted to one even if they needed such care, while more than six in 10 (61%) feel similarly anxious about the prospect of admitting family members, according to the latest survey from West Health and Gallup.
Safety was a particular area of perceived concern; 41% of respondents say nursing homes are not safe, 26% say they are, and about a third say they don’t know. Notably, the survey found that people over 35 were much ...
UTHealth Houston researcher to present abstract detailing new mouse model for brain arteriovenous malformations at NIH meeting
2023-09-12
An abstract unveiling a new mouse model for brain arteriovenous malformations (AVMs) developed by UTHealth Houston researchers has been selected for a poster presentation at the second annual National Institutes of Health (NIH) Investigator Meeting for Interoception Research in November.
Eunsu Park, PhD, assistant professor in the Vivian L. Smith Department of Neurosurgery with McGovern Medical School at UTHealth Houston, will present the abstract at the meeting, hosted by the National Center for Complementary and Integrative Health (NCCIH) at the NIH campus in Bethesda, Maryland, on Nov. ...
Combination of stressors key to testing perovskite solar cells
2023-09-12
Perovskite solar cells should be subjected to a combination of stress tests simultaneously to best predict how they will function outdoors, according to researchers at the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL).
Solar cells must endure a set of harsh conditions—often with variable combinations of changing stress factors—to judge their stability, but most researchers conduct these tests indoors with a few fixed stressing conditions. While these tests provide some necessary insight, understanding which stressor applied during indoor tests provided predictive correlations ...
Communicating stability, strong connections to stakeholders versus shareholders are priorities in Chinese financial reporting, Rotman research finds
2023-09-12
September 12, 2023 Toronto - It’s commonly accepted that U.S. and Chinese companies treat financial reporting and disclosure differently.
New research not only confirms that but digs into the motivations behind the distinction, using surveys with more than 200 Chinese executives who hold reporting responsibility. An overriding interest in communicating long-term stability and inspiring confidence in the company’s prospects among a diverse range of stakeholders, and not primarily shareholders, as in the U.S., was a signature driver for the Chinese business leaders.
“Acknowledging differences in approaches and incentives ...
Morris Animal Foundation funds 6 new studies to advance canine cancer research
2023-09-12
DENVER/Sept. 12, 2023 – Recent findings from the Golden Retriever Lifetime Study confirm the enormous impact of hemangiosarcoma on golden retrievers. To address critical gaps in disease detection and treatment, Morris Animal Foundation announced it is funding six studies focused on this deadly form of canine cancer.
“We are committed to providing resources to the top research teams in the world that can advance our understanding of hemangiosarcoma," said Dr. Kathy Tietje, Chief Program Officer at Morris Animal Foundation. "These innovative research ...
ReMDO grants support commercialization of regenerative medicine therapies
2023-09-12
WINSTON-SALEM, NC, September 12, 2023 - When the RegenMed Development Organization (ReMDO) offered its grant opportunity related to regenerative medicine manufacturing and commercialization, the result exceeded expectations.
The Regenerative Medicine Manufacturing grant call encouraged small, medium, and large companies to submit letters of interest with an accompanying white paper that addressed a gap in technical capabilities for one or more of the following topic areas: Cell and Biomaterial Manufacturing, Standards and Quality Control, Additive Manufacturing and Artificial Intelligence (AI) and Automation.
The grant opportunity will ...
Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cells
2023-09-12
A standard chemotherapy drug injures surrounding non-cancer cells, which can then awakens dormant cancer cells and promotes cancer growth, according to a new study publishing September 12th in the open access journal PLOS Biology by Ramya Ganesan of Emory University, US, and colleagues. The finding is important for understanding cancer recurrence and may point to important new targets to prevent it.
Advances in cancer treatment, including chemotherapy, have dramatically reduced mortality for many types of cancer, including breast cancer. Nonetheless, up to 23% of breast cancer patients experience recurrence within the first five years. Treatment is meant to kill all cancer cells, ...
Disease-resistant rice and wheat plants may modulate disease susceptibility in their neighbors
2023-09-12
Growing several plant varieties in the same field for disease resistance is a longstanding agricultural practice, but can have unpredictable results. A study publishing September 12th in the open access journal PLOS Biology by Jean-Benoit Morel at Institut National de Recherche pour l'Agriculture l'Alimentation et l'Environnement, Montpellier, France, and colleagues suggests that plant-to-plant interactions may confer disease immunity in both wheat and rice.
Neighbor-Modulated Susceptibility (NMS) occurs when healthy, same-species ...
LAST 30 PRESS RELEASES:
Twelve questions to ask your doctor for better brain health in the new year
Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes
Study identifies genetic cause for yellow nail syndrome
New drug to prevent migraine may start working right away
Good news for people with MS: COVID-19 infection not tied to worsening symptoms
Department of Energy announces $179 million for Microelectronics Science Research Centers
Human-related activities continue to threaten global climate and productivity
Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued
Unraveling the power and influence of language
Gene editing tool reduces Alzheimer’s plaque precursor in mice
TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies
Twisted Edison: Bright, elliptically polarized incandescent light
Structural cell protein also directly regulates gene transcription
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
Brain map clarifies neuronal connectivity behind motor function
Researchers find compromised indoor air in homes following Marshall Fire
Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality
Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology
'Glass fences' hinder Japanese female faculty in international research, study finds
Vector winds forecast by numerical weather prediction models still in need of optimization
New research identifies key cellular mechanism driving Alzheimer’s disease
Trends in buprenorphine dispensing among adolescents and young adults in the US
Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility
Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity
Association of state cannabis legalization with cannabis use disorder and cannabis poisoning
Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders
Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals
Unlocking the mysteries of the human gut
High-quality nanodiamonds for bioimaging and quantum sensing applications
New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia
[Press-News.org] COVID-19 can trigger auto-immune disorders-related antibodies, causing thrombosis and other complicationsA study conducted at the University of São Paulo helps explain why older people are more susceptible to the severe form of the disease and why it involves blood clotting disorders